Nachrichten zur DexCom Inc. Aktie

3 Beaten-Down Stocks That May Be Due for Big Comebacks in 2025

The past year was a great one for the stock market as a whole, but there were plenty of companies…

These Were the 5 Worst-Performing Stocks in the Nasdaq-100 in 2024

Now that weve shut the door on 2024, its useful to look back at some of the best -- and,…

DexCom, Abbott Agree to Settlement in Patent Litigation

…

DexCom (DXCM) Soars 5.6%: Is Further Upside Left in the Stock?

DexCom (DXCM) saw its shares surge in the last session with trading volume being higher than average. The latest trend…

1 Reason to Sell DexCom Stock, and 1 Reason to Buy

Shares of the medical-device maker DexCom (NASDAQ: DXCM) are down by 37% this year. The diabetes-focused healthcare company disappointed investors…

2025 Picks: 2 Stocks to Buy Now for 50% Upside

Two S&P 500 stocks--DexCom and Albemarle--are already on sale for investors to buy in 2025.…

DXCM Stock Gains on the Launch of Proprietary Generative AI Platform

Dexcom announces the first Generative AI platform in glucose biosensing.…

Dexcoms over-the-counter glucose monitor now offers users an AI summary of how sleep, meals and more impact sugar levels

Dexcom is bringing generative AI to Stelo users, starting with weekly personalized reports about their glucose…

DexCom: Brighter 2025 From Stelo Ramp

…

Dexcom shares up as Diabetes Association updates guidelines By Investing.com

Dexcom shares up as Diabetes Association updates guidelines…

How to buy a health care turnaround story at a discount using options

Tony Zhang describes selling a cash secured put in Dexcom.…

United Kingdom Diabetes Device Market Forecast Report 2024-2032: Competitive Landscape, SWOT, Porters Five Forces, Reimbursement Policies, Key Segments

The major participants in the United Kingdom Diabetes Device market includes Abbott Laboratories, Roche, Medtronic, Novo Nordisk A/S, Terumo Corporation,…

DexCom, Orthofix, Spire Global, and Moderna Investigation Alert: Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information

SAN DIEGO, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP investigates potential violations of federal and state…

3 Reasons to Buy DexCom Stock Like Theres No Tomorrow

Medical device specialist DexCom (NASDAQ: DXCM) is going through a rough patch. The companys shares are down sharply year to…

2 Excellent Healthcare Stocks to Hold Through the Next Decade

Although excellent medical care is always in high demand, the healthcare sector continuously evolves. Companies arent automatically worth investing in…

[Latest] Global Point of Care Glucose Testing Market Size/Share Worth USD 5,455.3 Million by 2033 at a 4.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global…

These Are the 5 Worst-Performing Stocks in the Nasdaq-100 With 2024 Almost Over

The Nasdaq-100 index tracks the largest 100 non-financial companies on the Nasdaq stock exchange. Although its not a part of…

2 Superior Growth Stocks to Buy Right Now If You have $1,000 to Invest

Its not always easy to be a long-term investor, particularly when contending with the natural cyclicality that the stock market…

DexCom and OURA Ink Partnership for Metabolic Health Innovation

DXCM and smart ring maker, OURA, join forces to help individuals make informed decisions regarding diet, exercise and overall well-being.…

Healthy Returns: Eli Lilly’s cholesterol pill impresses in mid-stage trial

Eli Lilly’s cholesterol pill impressed in a mid-stage trial. Meanwhile, Dexcom invested $75 million in Oura.…

Wall Streets Choppy Session: Big Tech Split as Markets Await Inflation Data

Dow drops 0.86%, S&P 500 slips below 6,000 while Nasdaq shows resilience. Amgen leads decliners, Dexcom tops gainers in mixed…

Aktie von Dexcom heute am Aktienmarkt gefragt (66,2833 €)

Am US-amerikanischen Aktienmarkt notiert die Aktie von Dexcom zur Stunde ein wenig fester. Die Aktie kostete zuletzt 70,61 US-Dollar. Die…

S&P 500 poised for weekly drop, Capri Holdings stock plummets on blocked Tapestry merger: Yahoo Finance

S&P 500 poised for weekly drop, Capri Holdings stock plummets on blocked Tapestry merger: Yahoo FinanceThe S&P 500 (^GSPC) is…

DexCom (DXCM) Q3 2024 Earnings Call Transcript

DXCM earnings call for the period ending September 30, 2024.…

DexCom Q3 Earnings Beat Estimates on Sensor Growth, Stock Rises

DXCMs third-quarter 2024 earnings and revenues surpass expectations, fueled by global growth in CGM adoption, strong Sensor sales and expansion…

DexCom, Inc. 2024 Q3 - Results - Earnings Call Presentation

…

Stocks making the biggest moves after hours: Dexcom, Capri, Skechers, Capital One and more

These are the stocks posting the largest moves in extended trading.…

Dexcom shares fall on slow revenue growth

Dexcom shares fell on Thursday after the company released third-quarter results that showed slow revenue growth…

After-hours movers: Capri Holdings, Skechers, DexCom, Western Digital and more By Investing.com

After-hours movers: Capri Holdings, Skechers, DexCom, Western Digital and more…

DexCom Q3 earnings beat estimates, but stock tumbles 16% on weak growth By Investing.com

DexCom Q3 earnings beat estimates, but stock tumbles 16% on weak growth…

DEXCOM ALERT: Bragar Eagel & Squire, P.C. is Investigating DexCom, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

NEW YORK, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

DXCM DEADLINE: RLF, A LEADING LAW FIRM, Encourages DexCom, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important October 21 Deadline in Securities Class Action – DXCM

NEW YORK, Oct. 21, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…

DexCom Aktie: Kurserholung und starke Performance

Die DexCom Aktie verzeichnete am 19. Oktober einen deutlichen Kursanstieg von 4,07% auf 72,38 USD. Dieser positive Trend setzt sich…

DXCM DEADLINE ALERT: DexCom, Inc. Investors are Notified of Imminent Monday October 21 Legal Deadline; Contact BFA Law if You Lost Money (Nasdaq:DXCM)

DexCom, Inc. investors that lost money on their investment are encouraged to contact BFA Law before October 21, 2024 legal…

SHAREHOLDER ALERT: Holzer & Holzer, LLC Reminds Investors of the October 21, 2024 Lead Plaintiff Deadline in Class Action Lawsuits Filed on Behalf of DexCom, Inc. (DXCM), Orthofix Medical Inc. (OFIX), and Spire Global, Inc. (SPIR) Shareholders

ATLANTA, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC reminds investors of the October 21, 2024…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Orthofix, Spire Global, DexCom, and Methode Electronics and Encourages Investors to Contact the Firm

NEW YORK, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

DexCom Q3 Preview: Walking On Eggshells With Its Channel Relationships

…

ROSEN, LEADING TRIAL ATTORNEYS, Encourages DexCom, Inc. Investors to Secure Counsel Before Important October 21 Deadline in Securities Class Action – DXCM

NEW YORK, Oct. 13, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…

DXCM SHAREHOLDER ALERT: A Securities Fraud Lawsuit was Filed against DexCom, Inc.; Investors are Urged to Contact BFA Law before October 21 Court Deadline (Nasdaq:DXCM)

DexCom, Inc. investors that lost money on their investment are encouraged to contact BFA Law before October 21, 2024 legal…

DexCom, Inc. (DXCM) Investors: October 21, 2024 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP

RADNOR, Pa., Oct. 12, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP…

ROSEN, LEADING INVESTOR COUNSEL, Encourages DexCom, Inc. Investors to Secure Counsel Before Important October 21 Deadline in Securities Class Action – DXCM

NEW YORK, Oct. 10, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Orthofix, Spire Global, DexCom, and Methode Electronics and Encourages Investors to Contact the Firm

NEW YORK, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

Down More Than 50% From Its High, Is DexCom Stock a Buy?

Is DexComs business in trouble, or could this be a great buying opportunity for investors?…

Down More Than 50% From Its High, Is DexCom Stock a Buy? @themotleyfool #stocks $DXCM

Is DexComs business in trouble, or could this be a great buying opportunity for investors?…

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DXCM

NEW YORK, Oct. 06, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Orthofix, Spire Global, DexCom, and Methode Electronics and Encourages Investors to Contact the Firm

NEW YORK, Oct. 05, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

DXCM LITIGATION ALERT: DexCom, Inc. Investors are Notified to Contact BFA Law before Imminent October 21 Deadline in Securities Fraud Class Action (Nasdaq:DXCM)

DexCom, Inc. investors that lost money on their investment are encouraged to contact BFA Law before October 21, 2024 legal…

Dexcom-Aktie: Kurs klettert leicht (62,3866 €)

Im Plus liegt aktuell der Anteilsschein von Dexcom . Zuletzt zahlten Investoren für das Papier 68,44 US-Dollar. Eine Verteuerung in…

DXCM Deadline Approaching on October 21, 2024: Kessler Topaz Meltzer & Check, LLP Reminds DexCom, Inc. (DXCM) Investors of Class Action Lawsuit Deadline

RADNOR, Pa., Oct. 04, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP…

Down More Than 50%, Is DexCom Stock a Bargain Now? @themotleyfool #stocks $DXCM $ABT

Demand for blood glucose monitors is strong, but DexCom isnt the only competitor in this lucrative market.…